EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury

Robert J Fontana, Einar S Bjornsson, Rajender Reddy, Raul J Andrade

Clinical Gastroenterology and Hepatology · 2023-07 · 21 (8) · 2088-2099

DOI: 10.1016/j.cgh.2022.12.040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-07. Verfasst von Robert J Fontana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan. Electronic address: rfontana@med.umich.edu. Hauptthemen laut MEDLINE: COVID-19, Chemical and Drug Induced Liver Injury, Liver Diseases, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Novo Nordisk, Spark Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiosyncratic drug-induced liver injury (DILI) is an infrequent but important cause of liver disease. Newly identified causes of DILI include the COVID vaccines, turmeric, green tea extract, and immune checkpoint inhibitors. DILI is largely a clinical diagnosis of exclusion that requires evaluation for more common causes of liver injury and a compatible temporal association with the suspect drug. Recent progress in DILI causality assessment includes the development of the semi-automated revised electronic causality assessment method (RECAM) instrument. In addition, several drug-specific HLA associations have been identified that can help with the confirmation or exclusion of DILI in individual patients. Various prognostic models can help identify the 5%-10% of patients at highest risk of death. Following suspect drug cessation, 80% of patients with DILI fully recover, whereas 10%-15% have persistently abnormal laboratory studies at 6 months of follow-up. Hospitalized patients with DILI with an elevated international normalized ratio or mental status changes should be considered for N-acetylcysteine therapy and urgent liver transplant evaluation. Selected patients with moderate to severe drug reaction with eosinophilia and systemic symptoms or autoimmune features on liver biopsy may benefit from short-term corticosteroids. However, prospective studies are needed to determine the optimal patients and dose and duration of steroids to use. LiverTox is a comprehensive, freely accessible Web site with important information regarding the hepatotoxicity profile of more than 1000 approved medications and 60 herbal and dietary supplement products. It is hoped that ongoing "omics" studies will lead to additional insight into DILI pathogenesis, improved diagnostic and prognostic biomarkers, and mechanism-based treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Chemical and Drug Induced Liver InjuryLiver DiseasesDrug-Related Side Effects and Adverse ReactionsHumansRisk Factors

Stichwörter der Autor:innen

Acute Liver FailureCausality AssessmentDrug Hepatotoxicity

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan. Electronic address: rfontana@med.umich.edu.
  • Deparment of Internal Medicine, Landspitali University Hospital, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Division of Gastroenterology and Hepatology, University Hospital-IBIMA Platform BIONAND, University of Malaga, CIBERehd, Spain.

Förderung

  • Novo Nordisk
  • Spark Therapeutics

Zitieren

APA

Fontana, R. J., Bjornsson, E. S., Reddy, R., & Andrade, R. J. (2023). The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury. Clinical Gastroenterology and Hepatology, 21(8), 2088-2099. https://doi.org/10.1016/j.cgh.2022.12.040

Vancouver

Fontana RJ, Bjornsson ES, Reddy R, Andrade RJ. The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury. Clinical Gastroenterology and Hepatology. 2023;21(8):2088-2099. doi:10.1016/j.cgh.2022.12.040

BibTeX
@article{Fontana2023,
  author = {Fontana, Robert J and Bjornsson, Einar S and Reddy, Rajender and Andrade, Raul J},
  title = {The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {8},
  pages = {2088--2099},
  doi = {10.1016/j.cgh.2022.12.040}
}
Kostenlos starten →